MMP9 and neoplasm: Jelena Roncevic observes that high levels of MMP-9 in PTC patients with unfavorable clinicopathological features, including the presence of lymph node metastasis, extrathyroidal invasion, large tumor size, and advanced TNM stage, which confirms the important role of MMP-9 in the progression of tumor and the prognosis of patients [81].